{"id":"https://openalex.org/W7215995940","doi":"https://doi.org/10.1158/1535-7163.c.8750713","title":"Data from Bortezomib Restores Venetoclax Sensitivity in Acute Myeloid Leukemia Cell Lines with Intrinsic and Acquired Resistance","display_name":"Data from Bortezomib Restores Venetoclax Sensitivity in Acute Myeloid Leukemia Cell Lines with Intrinsic and Acquired Resistance","publication_year":2026,"publication_date":"2026-10-02","ids":{"openalex":"https://openalex.org/W7215995940","doi":"https://doi.org/10.1158/1535-7163.c.8750713"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.8750713","doi":"https://doi.org/10.1158/1535-7163.c.8750713","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.8750713","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.c.8750713","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5155609180","display_name":"Chengxi Li","orcid":"https://orcid.org/0009-0001-6304-7442","observed_orcids":["https://orcid.org/0009-0001-6304-7442"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chengxi Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-6304-7442","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069439605","display_name":"Yu\u2010Hsuan A. Chang","orcid":"https://orcid.org/0000-0003-2705-655X","observed_orcids":["https://orcid.org/0000-0003-2705-655X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu-Hsuan Chang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2705-655X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130704883","display_name":"Minori Maki","orcid":"https://orcid.org/0009-0002-7066-2184","observed_orcids":["https://orcid.org/0009-0002-7066-2184"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Minori Maki","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-7066-2184","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088108345","display_name":"Ikuko Omori","orcid":"https://orcid.org/0000-0002-8040-8764","observed_orcids":["https://orcid.org/0000-0002-8040-8764"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ikuko Omori","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8040-8764","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102884391","display_name":"Naru Sato","orcid":"https://orcid.org/0000-0003-0452-3194","observed_orcids":["https://orcid.org/0000-0003-0452-3194"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naru Sato","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0452-3194","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086241483","display_name":"Susumu Goyama","orcid":"https://orcid.org/0000-0002-9339-1826","observed_orcids":["https://orcid.org/0000-0002-9339-1826"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susumu Goyama","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9339-1826","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054497666","display_name":"Toshio Kitamura","orcid":"https://orcid.org/0000-0001-7855-1767","observed_orcids":["https://orcid.org/0000-0001-7855-1767"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshio Kitamura","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7855-1767","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5079737516","display_name":"Yutaka Enomoto","orcid":"https://orcid.org/0000-0002-6346-9362","observed_orcids":["https://orcid.org/0000-0002-6346-9362"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yutaka Enomoto","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6346-9362","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.025200000032782555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12582","display_name":"Flavonoids in Medical Research","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9340000152587891},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9990000128746033},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.996999979019165},{"id":"https://openalex.org/keywords/bcl-2-inhibitor-resistance","display_name":"BCL-2 inhibitor resistance","score":0.8220000267028809},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.8100000023841858},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6790000200271606},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.7929999828338623},{"id":"https://openalex.org/keywords/pmaip1","display_name":"Noxa","score":0.7429999709129333},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.7419999837875366},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.824999988079071},{"id":"https://openalex.org/keywords/ras-mutations","display_name":"RAS mutations","score":0.6930000185966492},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.9549999833106995},{"id":"https://openalex.org/keywords/relapsed-aml","display_name":"relapsed AML","score":0.6340000033378601}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.9169999957084656},{"id":"https://openalex.org/C9583187","wikidata":"https://www.wikidata.org/wiki/Q7919510","display_name":"Ven","level":2,"score":0.8033000230789185},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.7422000169754028},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6434999704360962},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5968000292778015},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5924000144004822},{"id":"https://openalex.org/C2994294914","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired resistance","level":3,"score":0.5236999988555908},{"id":"https://openalex.org/C2779176958","wikidata":"https://www.wikidata.org/wiki/Q18028939","display_name":"MCL1","level":4,"score":0.5116000175476074},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4684000015258789},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.45840001106262207},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.435699999332428},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.42399999499320984},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4235999882221222},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.3905999958515167},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.3776000142097473},{"id":"https://openalex.org/C27740335","wikidata":"https://www.wikidata.org/wiki/Q14878333","display_name":"Proteasome","level":2,"score":0.375},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3504999876022339},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.34279999136924744},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.3215999901294708},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3057999908924103},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2897000014781952},{"id":"https://openalex.org/C2777453290","wikidata":"https://www.wikidata.org/wiki/Q18031090","display_name":"RELB","level":5,"score":0.28769999742507935},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.27219998836517334},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.25529998540878296},{"id":"https://openalex.org/C204258353","wikidata":"https://www.wikidata.org/wiki/Q7670282","display_name":"THP1 cell line","level":3,"score":0.25529998540878296}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.c.8750713","doi":"https://doi.org/10.1158/1535-7163.c.8750713","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.8750713","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.8750713","doi":"https://doi.org/10.1158/1535-7163.c.8750713","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.8750713","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7140672247","https://openalex.org/W4416842582","https://openalex.org/W7215717337","https://openalex.org/W7216099795","https://openalex.org/W7215837102","https://openalex.org/W3033975532","https://openalex.org/W2980235102","https://openalex.org/W7215958679","https://openalex.org/W7216037521","https://openalex.org/W7148912436"],"abstract_inverted_index":{"Abstract":[0],"Venetoclax":[1],"(VEN),":[2],"a":[3,11,72,110,122,157,204,237,244],"selective":[4],"BCL-2":[5],"inhibitor,":[6,112],"effectively":[7],"induces":[8],"apoptosis":[9,120],"in":[10,33,80,102,118,121,160,185,216,251],"wide":[12,123],"range":[13,124],"of":[14,45,56,125,130,163,166,192,200],"malignancies.":[15],"VEN-based":[16,69,220],"regimens,":[17,52],"which":[18,147,212],"combine":[19],"VEN":[20,96,117,167,195,226,249],"with":[21,36,82,116,176,203],"either":[22],"hypomethylating":[23],"agents":[24],"or":[25,132],"low-dose":[26],"cytarabine,":[27],"have":[28],"markedly":[29],"improved":[30],"treatment":[31,92],"outcomes":[32],"elderly":[34],"patients":[35,46,81],"acute":[37],"myeloid":[38],"leukemia":[39],"(AML).":[40],"However,":[41],"approximately":[42],"one":[43],"third":[44],"exhibit":[47],"intrinsic":[48,64],"resistance":[49,67,178,224,250],"to":[50,68,75,89,94,179,225,247],"these":[51],"and":[53,65,145,150,168,194,222],"the":[54,99,161,164,190,198,229,240],"majority":[55],"initial":[57],"responders":[58],"eventually":[59],"develop":[60],"acquired":[61,66,177],"resistance.":[62,97,188],"Therefore,":[63],"regimens":[70,221],"remains":[71],"major":[73],"barrier":[74],"achieving":[76],"durable":[77],"clinical":[78],"responses":[79],"AML.":[83],"In":[84],"this":[85,103,234],"study,":[86,104],"we":[87,105],"aimed":[88],"identify":[90],"effective":[91],"strategies":[93],"overcome":[95,248],"Among":[98],"drugs":[100],"tested":[101],"found":[106],"that":[107],"bortezomib":[108],"(BTZ),":[109],"proteasome":[111],"showed":[113],"potent":[114],"synergy":[115],"inducing":[119],"AML":[126,173,206,218,253],"cell":[127,174,207],"lines,":[128],"irrespective":[129],"RAS":[131],"TP53":[133],"mutation":[134],"status.":[135],"Mechanistically,":[136],"BTZ":[137,171,193],"upregulates":[138],"proapoptotic":[139],"proteins":[140],"such":[141],"as":[142,243],"NOXA,":[143],"BIM,":[144],"PUMA,":[146],"neutralize":[148],"MCL1":[149],"promote":[151],"apoptosis.":[152],"Notably,":[153],"NOXA":[154],"upregulation":[155],"plays":[156],"critical":[158],"role":[159,184],"efficacy":[162],"combination":[165,191,242],"BTZ.":[169],"Moreover,":[170],"resensitized":[172],"lines":[175],"VEN,":[180],"further":[181],"supporting":[182],"its":[183],"overcoming":[186],"therapeutic":[187],"Importantly,":[189],"significantly":[196],"prolongs":[197],"survival":[199],"mice":[201],"inoculated":[202],"VEN-resistant":[205],"line":[208],"harboring":[209],"BAX":[210],"mutations,":[211],"are":[213],"commonly":[214],"observed":[215],"relapsed":[217],"following":[219],"confer":[223],"by":[227],"inhibiting":[228],"BAX-dependent":[230],"apoptotic":[231],"pathway.":[232],"Collectively,":[233],"study":[235],"provides":[236],"rationale":[238],"for":[239],"VEN\u2013BTZ":[241],"potential":[245],"strategy":[246],"certain":[252],"subsets.":[254]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-10-03T00:00:00"}